These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26851123)

  • 1. Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.
    Estus TL; Choudhary S; Pilbeam CC
    Bone; 2016 Apr; 85():123-30. PubMed ID: 26851123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.
    Choudhary S; Goetjen A; Estus T; Jacome-Galarza CE; Aguila HL; Lorenzo J; Pilbeam C
    J Biol Chem; 2016 Feb; 291(8):3882-94. PubMed ID: 26703472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A.
    Choudhary S; Santone E; Yee SP; Lorenzo J; Adams DJ; Goetjen A; McCarthy MB; Mazzocca AD; Pilbeam C
    Endocrinology; 2018 Jul; 159(7):2759-2776. PubMed ID: 29757436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
    Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
    J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of parathyroid hormone on Wnt signaling pathway in bone.
    Kulkarni NH; Halladay DL; Miles RR; Gilbert LM; Frolik CA; Galvin RJ; Martin TJ; Gillespie MT; Onyia JE
    J Cell Biochem; 2005 Aug; 95(6):1178-90. PubMed ID: 15962290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor.
    Yang Y; Lei H; Qiang YW; Wang B
    Mol Biol Cell; 2017 Jul; 28(13):1792-1803. PubMed ID: 28495797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
    Tobimatsu T; Kaji H; Sowa H; Naito J; Canaff L; Hendy GN; Sugimoto T; Chihara K
    Endocrinology; 2006 May; 147(5):2583-90. PubMed ID: 16484320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
    Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
    PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in primary neonatal murine osteoblasts.
    Tsingotjidou A; Nervina JM; Pham L; Bezouglaia O; Tetradis S
    Bone; 2002 May; 30(5):677-84. PubMed ID: 11996904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
    Choudhary S; Huang H; Raisz L; Pilbeam C
    Biochem Biophys Res Commun; 2008 Aug; 372(4):536-41. PubMed ID: 18501188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.
    Suzuki A; Ozono K; Kubota T; Kondou H; Tachikawa K; Michigami T
    J Cell Biochem; 2008 May; 104(1):304-17. PubMed ID: 17990294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
    Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
    PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone induces E4bp4 messenger ribonucleic acid expression primarily through cyclic adenosine 3',5'-monophosphate signaling in osteoblasts.
    Ozkurt IC; Pirih FQ; Tetradis S
    Endocrinology; 2004 Aug; 145(8):3696-703. PubMed ID: 15087429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.